The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation

The emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb) ensures that drug discovery efforts remain at the forefront of TB research. There are multiple different experimental approaches that can be employed in the discovery of anti-TB agents. Notably, inhibitors of MmpL3 are numer...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alice R. Moorey, Alejandro Cabanillas, Sarah M. Batt, Sonja Ghidelli-Disse, Beatriz Urones, Olalla Sanz, Joel Lelievre, Marcus Bantscheff, Liam R. Cox, Gurdyal S. Besra
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/a33fd1f698b0424ca7a367765fd2c89c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!